Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-29

Clinical Trial Update: Fibromyalgia and Naltrexone: The FINAL Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for fibromyalgia investigating naltrexone has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)

Snippet

Sponsor: Odense University Hospital | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED